|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.43/-0.46
|
企業價值
13.61M
|
資產負債 |
每股賬面淨值
0.79
|
現金流量 |
現金流量率
--
|
損益表 |
收益
152.43K
|
每股收益
0.07
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/02 07:38 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. |